Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Abbott has received CE Mark approval for a 2.25 mm version of its Xience V Everolimus Eluting Coronary Stent System that offers physicians a smaller stent based upon the proven efficacy, positive safety results and excellent deliverability of Xience V.
Subscribe to our email newsletter
The 2.25mm version of the Xience V stent will be launched immediately in the majority of European markets and select countries in Asia and Latin America. In addition to the 2.25mm stent, Xience V is available in stent diameters of 2.5mm, 2.75mm, 3mm, 3.5mm and 4mm for lesions 28mm or shorter.
The addition of the 2.25mm stent to the Xience V portfolio gives physicians access to a wider range of stent sizes for treating a variety of patient types. Xience V is an investigational device in the US and Japan, and is currently under review for approval by the FDA.